Download the whitepaper to gain insights that can help inform your PFS manufacturing
approach
As demand for pre-filled syringes (PFS) continues to accelerate, driven by the rise of
biologics, chronic disease therapies and patient-centric delivery, drug developers face
a growing set of technical and operational challenges in bringing these products to
market.
This whitepaper explores the complexities of PFS manufacturing, from managing sensitive
formulations to minimizing high-value product loss. It also examines strategies for
delivering precision in fill-finish operations while maintaining compliance with
evolving regulatory standards.
Drawing on Pfizer CentreOne’s deep sterile injectable (SI) expertise, this whitepaper
outlines practical strategies and established methods designed to help address
complexity and support the reliable, scalable production of high-quality PFS therapies.